Laboratory Centrifuge Equipment
The World Health Organization (WHO) fact sheet states that in 2017, non-communicable diseases (NCD) like cancer, cardiovascular disease, and diabetes were to blame for 70% of all fatalities worldwide. As a result, pharmaceutical companies are investing more money in the development of cost-effective treatments, which in turn is driving up demand for crucial lab supplies like centrifuges. Pharmaceutical companies heavily invest in R&D, according to statistics from the World Economic Forum 2015 (Astra Zeneca tops the list with an investment of 25.5% of its total revenue for the fiscal year 2014–15). Growing public health consciousness is fueling the expansion of the diagnostic market, which requires Laboratory Centrifuge Equipment.
